Rosacea

  • Cover Story
    Fri, 02/03/2012 - 12:25

    An update on recent news, research and treatment trends for acne and rosacea.

    A new study shows that combination light and thermal treatment for acne may lead to improved clinical outcomes, and a trial of isotretinoin for rosacea reveals that higher doses may be the key to treatment success.

  • Feature
    Fri, 09/09/2011 - 10:21

    A review of recent studies, news and trends related to acne and rosacea, including a look at two separate studies that link stress to the worsening of skin conditions.

  • Feature
    Wed, 05/04/2011 - 09:13

    An update of the latest research and trends.

    Trial Finds Vicept’s V-101 Cream Safe and Effective for Erythematotelangiectatic Rosacea

  • Editor's Message
    Thu, 03/31/2011 - 13:33

    The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the warning signs of this chronic and conspicuous facial disorder now estimated to affect more than 16 million Americans.

  • Cover Story
    Thu, 03/31/2011 - 11:08

    Although the etiology remains unclear, newer combination therapies are giving clinicians more options to manage rosacea.

    As any physician knows, it is much easier to treat a disease when the underlying pathophysiology is completely understood; with an unknown etiology, several theories on treatment strategies and preferred courses of action are likely.

  • Feature
    Tue, 01/11/2011 - 15:37

    Recent research, news and treatment trends.

    Study Assesses the Effectiveness of Low-dose and Intermittent Oral Isotretinoin in the Treatment of Acne

    While the efficacy of conventional isotretinoin treatment (0.5 to 1.0 mg/kg per day for 16 to 32 weeks, reaching a cumulative dose of 120mg/kg) for acne has been well established, there also are many reports regarding the efficacy of low-dose and intermittent isotretinoin treatment in acne patients.

  • FDA Approvals and News
    Wed, 06/09/2010 - 11:11

    FDA Approvals & News

    KCI Announces FDA Clearance of V.A.C. Therapy for Venous Insufficiency Ulcers

    Kinetic Concepts, Inc., (KCI) recently announced that it has received 510(k) clearance from the FDA to market its proprietary Vacuum Assisted Closure, or V.A.C. Therapy System, for the treatment of venous insufficiency ulcers, also known as venous leg ulcers (VLUs).

    According to KCI, VLUs are often hard-to-heal, recalcitrant wounds that pose significant clinical challenges. They can be painful and debilitating, seriously impacting a patient’s physical and emotional quality of life

  • Feature
    Wed, 04/14/2010 - 08:44

    Highlights of recent news, research and treatment trends.

    Rosacea Awareness Month to Highlight Growing Incidence of Widespread Disorder

    According to the National Rosacea Society (NRS), although the number of people with rosacea continues to rise, most people fail to recognize the warning signs of this disorder, which is now estimated to affect well over 16 million Americans. The NRS has designated April as Rosacea Awareness Month to alert the public to the signs and symptoms of this chronic and conspicuous facial condition and to emphasize the importance of seeking medic

  • Feature
    Wed, 04/14/2010 - 07:02

    Dr. Fried, who is a psychologist as well as a dermatologist, discusses the burden rosacea places on the lives of its sufferers in terms of the blow to their pride and the prejudice of others to whom their disorder is all too apparent.

    We all attempt to “put our best face forward” in our efforts to gain acceptance and achieve success in life. Ever cognizant of our plethora of imperfections and frailties, we learn techniques to mask and hide these “dirty little secrets” from the world. Personality styles utilizing humor, humility, false bravado, condescension, critical appraisal and pr

  • Helpful Handouts
    Mon, 04/12/2010 - 15:07

    As the handout Drs. Danby and Margesson have created makes clear, rosacea can be difficult to pin down, largely because of its different forms and its similarity to and overlap with disorders with which it can in fact co-exist.

    Beyond the “rosy” flushing/blushing that describes its classic form, are these four subtypes with a total of six components:

    1. erythematotelangiectatic rosacea — with the two
    vascular components, telangiectasias and erythema
    2. papulopustular rosacea — with two acne-like features,
    papules and pustules
    3. phymatous rosacea — with skin thickening
    (W

  • Editor's Message
    Mon, 04/12/2010 - 11:16

    The National Rosacea Society reports that more Americans than ever have rosacea — the society recently announced that the estimated number of Americans now suffering from rosacea has increased to 16 million, up 2 million from previous estimates. Rosacea is a frustrating and embarrassing disorder for patients.

  • The Dermatologist’s Board Review
    Wed, 03/10/2010 - 12:50

    The content of these questions and answers are taken from the Galderma Pre-Board Slide Seminar.

    The course was most recently held July 17 to 19, 2009, at the Crowne Plaza Chicago O’Hare, Rosemont, IL.

    1. The histology of this condition is characterized by:

    a) alternating orthokeratosis and parakeratosis.
    b) intense spongiosis.
    c) dyskeratosis.
    d) nodular dermal inflammatory infiltrates.
    e) eosinophilic vasculitis.

    2. Azathioprine is used for this condition. Azathioprine:

    a) levels are reduced by allopurinol.
    b) is a pregnancy categ

  • Feature
    Thu, 12/10/2009 - 12:38

    A look at new and exciting advances in the field of dermatology.

  • Editor's Message
    Fri, 08/14/2009 - 08:56

    This month’s issue focuses on treating acne and rosacea, two conditions that present regularly to dermatology offices across the country and that plague patients of all ages. Here’s a look at some of the content from this issue.

    In this month’s cover story, which begins on page 24, Managing Editor Ellen Meyer highlights recent research and trends in the Acne and Rosacea Review. If you missed the American Academy of Dermatology’s summer meeting in Boston last month or attended but didnt have a chance to view all the posters, this review includes a roundup of the acne posters presented as we

  • Feature
    Thu, 08/13/2009 - 13:42

    Tetracycline, minocycline and doxycycline comprise a powerful and effective group of anti-acne agents, termed the tetracyclines. These agents are believed to function by both suppressing growth of Propionibacterium acnes and by exerting a direct anti-inflammatory effect.1 More recently, sub-antimicrobial dose doxycycline has demonstrated superb efficacy as a first-line rosacea treatment. Thus, despite increased bacterial antibiotic resistance, therapeutic efficacy persists due to anti-inflammatory effects of tetracyclines.1

    The first tetracycline antibiotic, chlortetracycline, was introduc

  • Thu, 08/13/2009 - 10:50

    Highlights of new research and treatment trends.

    ____________________________

    National Rosacea Society Awards New Grants for Rosacea Research

    The National Rosacea Society has awarded funding to four new studies.

    • Dr. Robert W. Walters, assistant professor, Division of Dermatology, and Dr. Robert J. Lefkowitz, professor, Department of Medicine, Duke University Medical Center, received $25,000 to study the role of beta-arrestin in cutaneous flushing.

    • Dr. Curdin Conrad, senior postdoctoral research fellow, Department of Immunology, MD Anderson Cancer Center, a

  • Feature
    Thu, 09/04/2008 - 15:34

     

    A variety of conditions overlap with acne and affect the course and effectiveness of treatment. From a treatment standpoint, these conditions most importantly include seborrheic dermatitis and rosacea. From a diagnosis standpoint, important overlaps to recognize include the follicular occlusion tetrad (two or more of the following: cystic acne, hidradenitis suppurativa, dissecting cellulitis, pilonidal cysts), SAPHO syndrome and PAPA syndrome.

    This article will review these acne overlaps and suggest therapeutic approaches.

    SEBORRHEIC DERMATITIS